9048
M. V. Voronkov et al. / Tetrahedron 60 (2004) 9043–9048
5H); 13C (75 MHz; CDCl3): d 14.1, 19.7, 23.3, 34.0, 48.0,
48.8, 53.9, 58.6, 62.7, 128.2, 128.9, 129.1, 137.8, 167.7.
1.75 (m, 8H), 2.33–2.47 (m, 5H), 3.42 (s, 2H), 3.44–3.51
(m, 1H), 3.59–3.74 (m, 4H), 4.95 (d, 1H, JZ6.5 Hz), 7.22–
7.35 (m, 5H); 13C (75 MHz; CDCl3): d 17.2, 19.6, 20.3,
23.9, 26.4, 27.4, 42.2, 44.6, 52.7, 53.5, 63.8, 64.1, 81.1,
127.5, 128.5, 129.4, 137.7, 167.3, 177.7.
3.4. Preparation of oxazoline 4a
To a vigorously stirred solution of 7a (23 mg, 0.1 mmol) in
2 mL of acetonitrile was added BF3$OEt2 (0.5 mmol) over
5 min at 0 8C. The resulting solution was stirred at room
temperature for 7 h, at which point TLC indicated that no
starting material remained. The reaction mixture was
concentrated, re-dissolved in 10 mL of ethanol, heated at a
gentle reflux for 3 h, then filtered through a silica gel plug
and concentrated in vacuo to yield 24 mg (89%) of 4a.
3.5.4. Compound 1r. Amorphous solid. 1H (300 MHz;
CDCl3): d 0.81–1.24 (m, 6H), 1.58–1.74 (m, 6H), 3.07–3.36
(m, 4H), 3.49–3.82 (m, 3H), 3.69 (s, 2H), 4.23–4.50 (m,
2H), 4.71 (d, 1H, JZ6.7 Hz), 6.56 (d, 1H, JZ14.2 Hz),
7.25–7.41 (m, 7H), 7.51–7.65 (m, 3H); 13C (75 MHz;
CDCl3): d 14.6, 17.3, 23.9, 34.4, 47.3, 48.5, 58.9, 59.8, 63.4,
68.9, 78.5, 114.9, 127.6, 127.9, 128.5, 128.8, 128.9, 129.0,
135.6, 137.5, 141.2, 167.9, 193.2.
3.4.1. Compound 4a. Clear oil.9 1H (300 MHz; DMSO-d6):
d 0.92–1.27 (m, 6H), 1.35–1.61 (m, 6H), 1.72 (s, 3H), 2.24–
2.72 (m, 6H), 3.41–3.47 (m, 1H), 4.19 (dt, 1H, JZ6.6,
7.4 Hz), 5.04 (d, 1H, JZ6.6 Hz); 13C (75 MHz; DMSO-d6):
d 13.9, 17.9, 19.2, 19.7, 23.7, 26.8, 43.2, 54.6, 54.7, 63.8,
71.5, 75.4, 171.2, 174.1.
References and notes
1. (a) Rich, D. H.; Sun, C. Q.; Prasad, J. V. N. V.; Pathiasseril, A.;
Toth, M. V.; Marshall, G. R.; Clare, M.; Mueller, R. A.;
Houseman, K. J. Med. Chem. 1991, 34, 1222. (b) Mimoto, T.;
Imai, J.; Kisanuki, S.; Enomoto, H.; Hattori, N.; Akaji, K.;
Kiso, Y. Chem. Pharm. Bull. 1992, 40, 2251.
3.5. General procedure for the preparation of the library
set 1
To a vigorously stirred solution of 7 or 8 (0.1 mmol) in 2 mL
of dichloromethane, 0.5 mmol of the corresponding nitrile
was added, followed by dropwise addition of 0.5 mmol of
BF3$OEt2 over 5 min at 0 8C. The reaction mixture was
stirred at room temperature for 24 h, at which point TLC
indicated no starting glycidic amides remained. The
reaction mixture was quenched with 2 mL of saturated
aqueous NaHCO3 and stirring was continued for 12 h. The
organic layer was separated, dried over magnesium sulfate
and concentrated in vacuo. Purification of the product was
accomplished ‘catch and release technique’: the solution of
the crude product mixture in methanol was passed through a
column packed with SCX modified silica. The non-basic
impurities were washed off the column with excess of
methanol and the retained product was then released with
1 M methanolic ammonia.
2. (a) Tam, T. F.; Carriere, J.; MacDonald, I. D.; Castelhano,
A. L.; Pliura, D. H.; Dewdney, N. J.; Thomas, E. M.; Bach, C.;
Barnett, J.; Chan, H.; Krantz, A. J. Med. Chem. 1992, 35, 1318.
(b) Chen, J. J.; Coles, P. J.; Arnold, L. D.; Smith, R. A.;
MacDonald, I. D.; Carriere, J.; Krantz, A. Bioorg. Med. Chem.
Lett. 1996, 6, 435. (c) Cardillo, G.; Tolomelli, A.; Tomasini, C.
Eur. J. Org. Chem. 1999, 155. (d) Takashiro, E.; Hayakawa, I.;
Nitta, T.; Kasuya, A.; Miyamoto, S.; Ozawa, Y.; Yagi, R.;
Yamamoto, I.; Shibayama, T.; Nakagawa, A.; Yabe, Y.
Bioorg. Med. Chem. 1999, 7, 2063. (e) Semple, J. E.; Owens,
T. D.; Nguyen, K.; Levy, O. E. Org. Lett. 2000, 2, 2769.
3. (a) Zvonkova, E. N.; Bushnev, A. S.; Aksenov, N. E.;
Golovanova, N. K.; Evstigneeva, R. P. J. Org. Chem. USSR
1974, 10, 1621. (b) Legters, J.; Van Dienst, E.; Thijs, L.;
Zwanenburg, B. Recl. Trav. Chim. Pays-Bas 1992, 111, 69.
(c) Ruano, J. L. G.; Paredes, C. G. Tetrahedron Lett. 2000, 41,
5357.
3.5.1. Compound 1a. Colorless amorphous solid.9 1H
(300 MHz; DMSO-d6): d 0.98–1.32 (m, 6H), 1.54–1.67
(m, 6H), 1.98 (s, 3H), 2.24–2.72 (m, 6H), 3.41–3.47 (m,
1H), 3.97–4.11 (m, 1H), 4.91 (br s, 1H), 5.04 (d, 1H, JZ
6.6 Hz), 8.11 (br s, 1H); 13C (75 MHz; DMSO-d6): d 13.2,
17.9, 19.5, 19.6, 23.8, 25.4, 42.0, 54.6, 54.7, 63.5, 71.5,
74.2, 170.2, 171.3.
4. Maly, D. J.; Huang, L.; Ellman, J. A. ChemBiochem 2002, 3,
16.
5. Glabe, A. R.; Sturgeon, K. L.; Ghizzoni, S. B.; Musker,
W. K.; Takahashi, J. N. J. Org. Chem. 1996, 61, 7212.
6. Under various coupling conditions (resin-bound-DCC,
PyBROP, etc.) LC/MS consistently indicated the correspond-
ing (M-74) fragment, which corresponds to the formal loss of
hydroxyacetic acid fragment, as a major component of the
reaction mixture.
3.5.2. Compound 1j. Off-white amorphous solid.9 1H
(300 MHz; CDCl3): d 1.17 (d, 3H, JZ6.4 Hz), 1.37 (d,
3H, JZ6.2 Hz), 1.31–1.38 (m, 1H), 1.92–1.98 (m, 1H),
2.37–2.46 (m, 4H), 3.52 (s, 2H), 3.49–3.70 (m, 4H), 3.79
(dq, 1H, JZ6.6 Hz, 6.2 Hz), 4.31–4.39 (m, 1H), 5.08 (d, 1H,
JZ6.6 Hz), 7.18–7.27 (m, 5H), 7.65–7.72 (m, 2H), 7.81–
7.84 (m, 1H), 8.14–8.19 (m, 1H); 13C (75 MHz; CDCl3): d
17.6, 20.7, 34.9, 42.3, 46.2, 54.6, 63.9, 64.5, 78.6, 125.4,
127.8, 128.8, 129.5, 133.5, 133.6, 137.9, 148.2, 166.3,
171.2.
7. Weinshenker, N. M.; Shen, C.-M. Tetrahedron Lett. 1972, 13,
3281.
8. Lawrence, R. M.; Biller, S. A.; Fryszman, O. M.; Poss,
M. A. Synthesis 1997, 553.
9. Due to racemic nature of the amine moiety, the product was
isolated as 1:1 mixture of diasteriomers.
10. However, excessive stabilization of positive charge on this
carbon (i.e. by aryl substituent) apparently leads to SN1 attack
and results in multiple products.
3.5.3. Compound 1n. Amorphous solid. 1H (300 MHz;
CDCl3): d 1.02 (t, 3H, JZ7.4 Hz), 1.22–129 (m, 6H), 1.52–
11. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune,
H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765.